Mailin Delgado, EDS, LMHC | |
3580 Mystic Pointe Dr, Aventura, FL 33180-2554 | |
(786) 702-4383 | |
Not Available |
Full Name | Mailin Delgado |
---|---|
Gender | Female |
Speciality | Counselor - Mental Health |
Location | 3580 Mystic Pointe Dr, Aventura, Florida |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1952076622 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103TS0200X | Psychologist - School | SS1539 (Florida) | Secondary |
101YM0800X | Counselor - Mental Health | MH18544 (Florida) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mailin Delgado, EDS, LMHC 1124 Ne 183rd St, North Miami Beach, FL 33179-4612 Ph: (786) 487-2004 | Mailin Delgado, EDS, LMHC 3580 Mystic Pointe Dr, Aventura, FL 33180-2554 Ph: (786) 702-4383 |
News Archive
Researchers from Leiden University Medical Center in the Netherlands used magnetic resonance imaging (MRI) to examine the brains of elderly patients with and without dementia related to Alzheimer's or Parkinson's disease.
Almost four out of five Australians (78%) report that they look for information about medicines on the internet, according to a new 2016 survey* released during Be Medicinewise Week (22-28 August).
A new study out of Chang Gung University School of Nursing in Taiwan suggests that people with cancer experience severe anxiety toward end of life, not solely due to proximity to death, but rather to factors related to psychosocial issues and disease burden.
Advanced Cell Technology, Inc. announced today that it filed an Investigational New Drug (IND) Application with the US Food and Drug Administration (FDA) to initiate a Phase I/II multicenter study using embryonic stem cell derived retinal cells to treat patients with Stargardt's Macular Dystrophy (SMD). Among the most common causes of untreatable blindness in the world are degenerative diseases of the retina.
› Verified 9 days ago